SSSamantha N. Serna
Samantha N. Serna
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samantha N. Serna has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Christopher A. Reilly
Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, Utah
2 shared publications - Lili Sun
Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, Utah
2 shared publications - Cassandra E. Deering-Rice
Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, Utah
1 shared publication - Changshan Niu
College of Pharmacy, University of Utah, Salt Lake City, UT 84108, USA
1 shared publication Eric W. Schmidt
Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah
1 shared publicationErin G. Romero
Department of Pharmacology and Toxicology, Center for Human Toxicology, University of Utah, Salt Lake City, Utah
1 shared publication
Latest Publications
- Open Access
- 28 August 2026
- Published by Elsevier in Molecular Pharmacology
- Vol. 108 (10) , 100153
Regulation of transient receptor potential ankyrin-1 agonist–induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase
- 28 August 2026
- Published by Elsevier in Molecular Pharmacology
- Vol. 108 (10) , 100153
Open AccessRegulation of transient receptor potential ankyrin-1 agonist–induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase
- Open Access
- 22 April 2025
- Published by Elsevier in Molecular Pharmacology
- Vol. 107 (6) , 100042
Bryostatins 1 and 3 inhibit TRPM8 and modify TRPM8- and TRPV1-mediated lung epithelial cell responses to a proinflammatory stimulus via protein kinase C
- 22 April 2025
- Published by Elsevier in Molecular Pharmacology
- Vol. 107 (6) , 100042
Open AccessBryostatins 1 and 3 inhibit TRPM8 and modify TRPM8- and TRPV1-mediated lung epithelial cell responses to a proinflammatory stimulus via protein kinase C